Ceralasertib (AZD6738) Mechanism of Action: ATR Inhibition in T Cell Research

Ceralasertib (AZD6738) MOA:Targeting ATR/DNA Damage Response Pathway for Tumor Immunotherapy Combination

🎯 check Ceralasertib (AZD6738) product page

Ceralasertib (AZD6738) is a potent, selective, ATP-competitive ATR inhibitor. It affects DNA damage response and ATR-Chk1 signaling by blocking Chk1 phosphorylation and inducing replication catastrophe, effectively inhibiting tumor cell proliferation and promoting apoptosis.

Primary Applications and Mechanism of Action